Stocktwits69d agoneutral
ABBV Stock Gains On Winning FDA Approval For Rare Blood Cancer DrugThe U.S. Food and Drug Administration (FDA) has approved pivekimab sunirine-pvzy (sold under the brand name Decnupaz), a highly targeted therapy for adults dealing with an ultra-rare and aggressive form of blood cancer.